The dual speci®city phosphatase and oncogene Cdc25B has been implicated in the G2/M cell cycle checkpoint, but the mode by which it is regulated remains poorly understood. Regional subcellular redistribution of proteins represents a unique potential regulatory mechanism. Thus, we examined in live cells the subcellular localization characteristics of Cdc25B 2 and Cdc25B 3 fused to green¯uorescent protein. Cdc25B 2 partitioned primarily in the cytoplasm during G1 and progressively migrated to the nucleus as cells transited from S to G2/ M phase. In contrast, Cdc25B 3 maintained a homogeneously staining diuse phenotype irrespective of cell cycle phase. Treatment of the Cdc25B 2 -green¯uorescent protein stable transfectants with vanadate inhibited the cell cycle dependency of intracellular distribution, while okadaic acid had little eect except in G1, suggesting regulation by at least one phosphorylation-dependent pathway. The DNA topoisomerase II poison and DNA damaging agent, etoposide, inhibited nuclear localization of Cdc25B 2 in S phase, possibly by invoking a sequestration cascade. Thus, dierences in the spatial distribution of Cdc25B subtypes exist within cells and the 41 amino acid insert in the N-terminus of the Cdc25B 3 splice variant encodes an important inhibitory determinant for such regulation. The subcellular redistribution of Cdc25B 2 could be functionally important for G2/M checkpoint regulation.
Introduction
Cyclin dependent kinases (Cdk) are essential proteins that together with a cyclin protein partner regulate the cell cycle progression. The prototype Cdk, Cdc2, is required for the transit of cells from the G2 cell cycle phase to mitosis. Opposing positive and negative regulators of Cdk ensure appropriate timing of these phase transitions such that genomic integrity is preserved with each cell division. Phosphorylation status at key sites on Cdk appears to be critical in many regulatory processes; for example, phosphorylation of Thr 14 and Tyr 15 by Wee1/Mik1 kinases or dephosphorylation of the same residues by Cdc25 result in Cdc2 inactivation or activation, respectively (Morgan, 1995) .
Most of our knowledge of the Cdc25 phosphatase family emanates from studies in yeast, which harbor only one cdc25 gene; in contrast, mammalian cells express at least three isotypes: Cdc25A, B and C, which share 40% homology and can complement cdc25 de®ciency in yeast (Galaktionov and Beach, 1991) . The mammalian counterpart to yeast Cdc25 is the Cdc25C isotype, for which the most mechanistic and functional information is available. Cdc25A and Cdc25B have been reported to have oncogenic properties . Cdc25B and Cdc25C appear to regulate the G2/M transition, while Cdc25A binds to cyclin E/Cdk2 and is involved in cell phase transitioning from G1 to S (Millar et al., 1991; Jinno et al., 1994; Gabrielli et al., 1996) . Recently, Ducommun and colleagues further strati®ed Cdc25B into three splice variants, Cdc25B 1 , Cdc25B 2 , and Cdc25B 3 (Baldin et al., 1997b) . Structurally, Cdc25B 3 is a full length 580 residue form while Cdc25B 1 lacks 14 residues and Cdc25B 2 lacks 41 residues (Baldin et al., 1997b) . Both of these small N-terminal deletions encode potential proline-directed phosphorylation sites. Cdc25B 3 is ubiquitously expressed in human and mouse cells, while Cdc25B 1 and Cdc25B 2 are often found at lower levels in some cell types. Functional dierences among the Cdc25B isotypes have been suggested with Cdc25B 2 and Cdc25B 3 being more pro®cient than Cdc25B 1 at rescuing yeast cells carrying a temperature-sensitive lethal Cdc25 nullifying mutation (Baldin et al., 1997b) . In vitro studies indicate that Cdc25B 2 and Cdc25B 3 subtypes have relatively high activity toward Cdk2/cyclin A activation and Cdc2/ cyclin B1 (Gabrielli et al., 1997a) . Interestingly, Cdc2/ cyclin B1, but not Cdk2/cyclin A is more readily activated by hyperphosphorylated Cdc25B 2 or Cdc25B 3 , implying diering regulatory pathways for Cdk/cyclin activation (Gabrielli et al., 1997a) . Thus, slight physical dierences among the Cdc25B subtypes are associated with measurable changes in the in vitro substrate binding anity, level of expression, as well as detectable functional dierences in regulating mitosis in yeast.
In addition to protein levels and phosphorylation status, the subcellular distribution of the Cdc25 family may be an important regulator of enzymatic activity. There is emerging evidence that Cdc25 phosphatases can interact with cytoplasmic proteins, such as members of the Raf1 and 14-3-3 families, linking signal transduction machinery to cell cycle control programs (Conklin et al., 1995; Galaktionov et al., 1995) . Thus, we have examined and compared the distribution of two important Cdc25B subtypes at various cell cycle stages in live cultures of Chinese hamster ovary cells stably transfected with either Cdc25B 2 or Cdc25B 3 fused to a red-shifted green uorescent protein variant (GFP). Secondly, we investigated whether phosphorylation may participate in the regulation or maintenance of the observed Cdc25B localization phenotypes. Finally, because DNA damage can alter the phosphorylation status of Cdc25C, we studied the eect of DNA damaging agent, etoposide, on Cdc25B localization.
Results

Stable expression of Cdc25B-GFP constructs in cells
Preliminary studies with transient transfectants showed varying levels of¯uorescence intensity and transfection eciency with the control (pEGFP-C1) transfectants showing both the highest¯uorescence intensity and eciency. Nevertheless, all distribution phenotypes observed later in the stable Cdc25B 2 transfectants were observed in the transiently transfected counterparts (data not shown). Synchronization experiments and careful comparisons, however, required more consistent expression, thus stable transfectants were generated.
CHO cells were transfected with plasmids p25B2-GFP (Figure 1 ), p25B3-GFP (Figure 1 ), or pEGFP-C1. p25B2-GFP and p25B3-GFP were identical except for the respective Cdc25B subtypes they carried; pEGFP-C1 contained only GFP. Stable transfectants were selected by growth in G418. We found only 25% of the cells transfected with the Cdc25B subtypes (75% of pEGFP-C1 transfectants) were¯uorescent using conventional epi¯uorescence. Thus, stable cell lines exhibiting high¯uorescence were isolated by three sequential rounds of FACS, where the cells with the highest¯uorescence cells were recovered each time. Both the second and third selection rounds showed 499% cells expressing their respective DNA constructs, as determined by microscopy. Subcellular localization of Cdc25B 2 but not Cdc25B 3 changes with cell cycle phase
We found no signi®cant modi®cation of the population doubling times of stable-transfectants expressing the GFP-Cdc25B 2 or GFP-Cdc25B 3 fusion proteins compared to nontransfected or GFP expressing CHO cells, consistent with a moderate expression level of GFP and the coexpression of either of the dual speci®city phosphatases. The GFP, Cdc25B 2 and Cdc25B 3 stable transfectants were synchronized by serum starvation and mimosine treatment, as shown in Figure 2 . Cell phase was assigned on the basis of DNA content, as determined by FACS analysis of propidium iodide treated cells. No appreciable increase in the percentage of G1 cells was apparent in serum starved versus mimosine treated cells 0 h after mimosine removal, although cells had presumably entered S phase at this time (Kruk et al., 1997) . Nonetheless, the predominate cell phase, at each of the time points was unambiguous, with a signi®cant majority of cells in G1 phase immediately upon mimosine removal (0 h after block release), S phase The subcellular localization of the Cdc25B 2 -GFP and Cdc25B 3 -GFP fusion proteins were visualized in synchronized live cells by¯uorescence microscopy ( Figure 3) . By comparing the dierential interference contrast images (Figure 3a ± c) with the¯uorescence images (Figure 3d ± f), a striking cell cycle dependent distribution of Cdc25B 2 was noted. During G1 phase some nuclear¯uorescence and bright punctate cytoplasmic staining was seen (Figure 3d ). During S phase, more cells appeared to assume a nuclear distribution of Cdc25B 2 with some cells displaying quite intense nuclear localization (Figure 3e ). During G2/M phase cells had mainly nuclear Cdc25B 2 ( Figure 3f ). Clear nuclear regions could be distinguished using dierential interference contrast optics (Figure 3 ), as well as Hoechst staining (data not shown). In contrast, we observed no changes in the¯uorescence pattern of Cdc25B 3 -GFP cells (Figure 3g ± i) and control GFP cells (Figure 3j ± l), which was diusely localized throughout the cell, irrespective of cell cycle phase. Quantitation of the Cdc25B 2 data is shown in Figure   4a , where cells were scored for the respectivē uorescence distribution phenotypes. Again, the punctate cytoplasmic staining, which we describe as cytoplasmic granules' were most prevalent at G1 (53%) and early S phase (48%), and decreased substantially by G2/M (33%). An inverse trend of increasing nuclear Cdc25B 2 localization occurred during the same time frame (G1: 22%, S: 33%, G2/ M: 50%), while the percentage of cells with a cytoplasmic phenotype decreased and the percentage of cells with a diusely stained phenotype, which extended throughout the cell, remained unchanged. Figure 4d clearly shows the maintenance of a diuse localization pattern for Cdc25B 3 throughout G1, S, and G2/M.
Vanadate is inhibitory to cell cycle dependent subcellular localization of Cdc25B 2 Treatment of Cdc25B 2 transfectants with 30 mM vanadate for 1 h markedly decreased the nuclear content and increased the diuse localization of GFPCdc25B 2 in G1 cells, but had no profound eect on S Figure 3 Subcellular localization of Cdc25B 2 and Cdc25B 3 in synchronized live cells. Cells with stable expression of p25B2-GFP (a ± f), p25B3-GFP (g ± i), or pEGFP-C1 (j ± l) were synchronized at G1 (a, d, g, j) , S (b, e, h, k), or G2/M (c, f, i, l) and were viewed (606). (a ± c) are dierential interference contrast, (d ± f) are epi¯uorescence. For (g ± l), images obtained by dierential interference contrast were overlaid on¯uorescence images. Bar, 10 mm phase distributions (Figure 4b) . At G2/M vanadate also caused a signi®cant 40% loss in the percentage of cells showing a nuclear distribution relative to untreated G2/M cells. Thus, vanadate neutralized the cell cycle dependent changes in cytoplasmic granule phenotypes and disrupted the nuclear phenotypes in both G1 and G2/M phases (Figure 4b ). Like vanadate, treatment of cells with the Ser/Thr phosphatase inhibitor, okadaic acid, caused a redistribution of nuclear and cytoplasmic Cdc25B 2 to a diuse phenotype in G1 cells, but had no eect at S phase (Figure 4c ). These data would be consistent with Tyr and Ser/Thr phosphorylation of some protein influencing Cdc25B 2 localization at G1 and with Tyr phosphorylation of some protein altering Cdc25B 2 localization at G2/M. It is recognized, however, that these phosphatase inhibitors could also have other pharmacological actions that may be responsible for the disruption in Cdc25B 2 sequestration. Finally, the diuse cellular distribution of Cdc25B 3 (Figure 4e and f) and GFP control cells (data not shown) was unaected by vanadate or okadaic acid.
Time lapse cinematography of stable transfectants
Using time lapse cinematography, we examined the kinesis of Cdc25B 2 and Cdc25B 3 in live cells in real time during the phase transition into mitosis. Figure 5 shows a representative experiment of Cdc25B 2 transfectants that were synchronized at G2/M and subsequently monitored for 2 h. Initially, nuclei were homogeneously stained (Figure 5a and b) , then assumed punctate nuclear staining characteristics after 80 min (Figure 5c ± e). The signi®cance of this change in intranuclear distribution is unknown, but may re¯ect cellular preparation for or movement through mitosis. Regardless, both intra-as well as intercompartmental kinesis of Cdc25B 2 were clearly observed in live cells, and occurred within a relatively short (min) time frame. No movement of Cdc25B 3 or GFP was detected in similar studies (data not shown).
Etoposide inhibits nuclear localization of Cdc25B 2
Recent studies have implicated Cdc25C sequestration in the DNA damage pathway leading to G2/M arrest due to the inability of Cdc25C to activate cyclin B1/ Cdc2 (Peng et al., 1997) . Our GFP chimeras were ideal reagents to test whether subcellular sequestration of Cdc25B 2 or Cdc25B 3 occurred in response to DNA damage. Topoisomerase II inhibitors, such as etoposide, cause DNA damage during S phase that results in either a G2/M arrest or apoptotic death. As illustrated in Figure 6a , treatment of cells with 30 mM of the anticancer agent etoposide during G1 phase resulted in a modest increase in nuclear sequestration of Cdc25B 2 with only minor dierences in the other compartments. In contrast, exposure of cells to the identical etoposide concentration in S phase resulted in a profound loss of nuclear Cdc25B 2 with a concomitant increase in both the cytoplasmic and diuse compartments (Figure 6b) . No marked changes were noted when cells were treated for 1 h during G2/M phase (Figure 6c) . Predictably, the diuse localization phenotypes of Cdc25B 3 and GFP control were maintained in the presence or absence of etoposide, irrespective of cell cycle phase (data not shown).
Discussion
Although both protein levels and phosphorylation help regulate the biological activity of the Cdc25 phosphatase family, additional control mechanisms appear to exist. Observations that Cdc25B protein levels and activity escalate during late S and G2 phases circumstantially place its action at the G2/M checkpoint, as does the G2/M delay shown in dominant negative Cdc25B HeLa cell mutants (Gabrielli et al., 1996; Lammer et al., 1998) . Recent results suggest Cdc25B may be a`starter phosphatase' that initiates the positive feedback loop at the entry into M phase (Lammer et al., 1998) . Several in vitro studies have indicated potential endogenous substrates for Cdc25 isotypes (Sebastian et al., 1993; Xu and Burke 1996) , although convincing in vivo veri®cation is only available for Cdc25C (Strausfeld et al., 1994; Homann et al., 1993) . Our data on the subcellular localization characteristics of the Cdc25B 2 subtype support the proposed role of Cdc25B 2 during late S and G2/M. As visualized in live cells, Cdc25B 2 existed primarily in the form of cytoplasmic granules during G1, which gradually declined as the cells progressed toward G2/M. An inverse trend of increasing nuclear Cdc25B 2 occurred concomitantly, such that the majority of cells exhibited nuclear Cdc25B 2 localization at G2/M. The sequestration of Cdc25B 2 in granules might prevent premature activation of Cdc2/ cyclin B complexes. These observations with Cdc25B 2 were in stark contrast to the subcellular localization characteristics of Cdc25B 3 , which was diusely localized throughout the cell irrespective of cell cycle phase, the addition of Ser/Thr or Tyr phosphatase inhibitors, or a DNA damaging agent. Our ®ndings with the GFP-fusion protein help resolve previously reported ambiguities surrounding the subcellular localization of Cdc25B. Using indirect immunofluorescence, Cdc25B was originally reported to be perinuclear and cytoplasmic in HeLa cells at prophase (corresponding to late G2), in contrast to the low intensity nuclear staining observed during interphase (Gabrielli et al., 1996) . Upon more careful analysis, these same investigators discovered prominent nuclear Cdc25B staining in S and G2 synchronized HeLa cells Figure 4 as well as after UV-irradiation, which delayed cells in G2 (Gabrielli et al., 1997b) . The resulting hypothesis (Gabrielli et al., 1997b) that transient nuclear accumulation of Cdc25B occurs in G2 phase is supported by our results. Thus, the transient nature of Cdc25B 2 nuclear localization combined with the apparent lack of Cdc25B 3 kinesis and the inability of Cdc25B antibodies to distinguish among the Cdc25B subtypes could easily account for previously observed inconsistencies in Cdc25B localization, particularly in asynchronous cell cultures.
Vanadate disrupted the cell cycle dependent localization trends for Cdc25B 2 , implying Tyr phosphorylation of some protein was inhibitory to proper Cdc25B 2 localization. There are no known phosphorylation sites on Tyr residues within Cdc25B 2 . Little data are available regarding the in vivo phosphorylation status of Cdc25B, although Ser/Thr kinase Cdc2/cyclin A has been reported to phosphorylate Cdc25B and target it for degradation (Baldin et al., 1997a) . Interestingly, okadaic acid had little eect on Cdc25B 2 location except in G1. Whether this G1 eect is due to perturbation of Ser/Thr residues on Cdc25B 2 is unknown. Recently it has been suggested that phosphorylation can control the subcellular localization of Cdc25C after DNA damage (Peng et al., 1997) .
A key component appears to be one or more members of the 14-3-3 family of proteins. Mammalian 14-3-3 proteins are typi®ed by their binding to phosphoserinecontaining proteins in multiple cell signaling pathways. Indeed, the RSXpSXP recognition motif for 14-3-3 proteins (Muslin et al., 1996) (Yae et al., 1997) . Thus, a mechanistic model for DNA damage leading to G2 arrest has emerged where DNA damage induces Rad3 (ATM in mammalian cells), leading to activating phosphorylation of Chk1 kinase. A parallel mechanism exists for mitotic arrest in the presence of unreplicated DNA using the Cds1 kinase (Zeng et al., 1998) . Both Chk1 and Cds1 phosphorylate Cdc25C on Ser216 permitting 14-3-3 binding (Peng et al., 1997; Sanchez et al., 1997) . Cells undergo G2 arrest because Cdc25C cannot activate Cdc2 in a 14-3-3-bound state (Peng et al., 1997) due to the physical sequestration of Cdc25, preventing its association and activation of Cdc2. It is possible a similar mechanism exists for Cdc25B. All three subtypes of Cdc25B contain multiple recognition motifs for 14-3-3 binding, which dier in location and number from that of Cdc25A and Cdc25C (Yae et al., 1997) ; however, none lie within the 41 amino acid sequence deleted from Cdc25B 2 . This suggests the involvement of other yet to be identi®ed sequestering partners for Cdc25. Our observation that etoposide treatment inhibited nuclear localization of Cdc25B 2 is consistent with a cytoplasmic sequestering mechanism. Indeed, etoposide has long been associated with G2 arrest, a phenomenon that may be attributed, in part, to the decrement in nuclear Cdc25B 2 . Interestingly, the activation of the cytoplasmic sequestration process by etoposide appeared to be initiated in S rather than G2/M phase.
Human Chk1 binds and phosphorylates all three human Cdc25 isotypes in vitro and indirect immunouorescence shows nuclear, punctate staining (Sanchez et al., 1997) . This raises the question of how Ser216-phosphorylated Cdc25 escapes the nucleus to be sequestered by cytoplasmic 14-3-3, only to be released at the appropriate time to activate Cdc2 or other cdk substrates in cytoplasmic or nuclear compartments. The capacity for Cdc25B 2 to shuttle eciently between nucleus and cytoplasm was demonstrated in our time lapse monitoring of Cdc25B 2 localization in live cells. We observed intranuclear kinesis as well as nuclear entry or egress of Cdc25B 2 to be a dynamic process, occurring within a time frame of minutes. We also show a gradual movement of Cdc25B 2 from the cytoplasm to nucleus during normal cell progression from G1 through S to G2/M, possibly re¯ecting Cdc25B 2 release from 14-3-3 or other sequestering proteins, and subsequent nuclear localization. No movement was seen with Cdc25B 3 . The ability to detect the cytoplasmic granules by¯uorescence microscopy indicated signi®cant aggregation and was not likely to re¯ect simple 14-3-3 dimerization, as suggested by Aitken (1996) . Our results revealed Cdc25B 2 sequestration was a feature of normal cell cycling, and may be exaggerated in response to DNA damage by parallel or overlapping pathways.
In summary we have documented that cell cycledependent kinesis of Cdc25B 2 but not Cdc25B 3 occurs in CHO cells. It appears a 41 amino acid region in the N-terminus of Cdc25B 3 encodes an important inhibitory determinant for this spatial distribution. A phosphorylation pathway was implicated based on the disrupting eects of vandate on Cdc25B 2 localization. The DNA damage that occurred in S phase with etoposide inhibited the nuclear sequestration of Cdc25B 2 . The subcellular redistribution of Cdc25B 2 could be functionally important for G2/M checkpoint regulation.
Materials and methods
Construction of GFP-Cdc25B vectors
Cdc25B 2 cDNA contained in pGEX-KG (Galaktionov and Beach, 1991) and Cdc25B 3 in pGEX-2T (GST-cdc25B, (Gabrielli et al., 1996) ) were gifts from Drs Beach (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA) and Gabrielli (Queensland Institute of Medical Research, Queensland, Australia) , respectively. p25B2-GFP (Figure 1 ) was constructed by inserting a 2.8 kb BamHI fragment containing Cdc25B 2 into the corresponding site in pEGFP-C1 (Clontech, Palo Alto, CA, USA) at the 3' end of enhanced green¯uorescent protein. To obtain p25B3-GFP, we digested GST-cdc25B, lacking the ®rst 6 bp of the Cdc25B 3 ORF, with BamHI and EcoRI. The 2.9 kb BamHI/EcoRI fragment containing Cdc25B 3 was inserted into pEGFP-C1 via BglII/ EcoRI sites. Insert orientation and integrity of both p25B2-GFP and p25B3-GFP were con®rmed by restriction mapping and sequencing. Restriction enzymes were obtained from New England Biolabs (Beverly, MA, USA) or GIBCO/BRL (Life Technologies, Grand Island, NY, USA). Cloning enzymes/kits were purchased through Amersham Life Science (Cleveland, OH, USA), Boehringer Mannheim (Indianapolis, IN, USA), Promega (Madison, WI, USA), and Qiagen (Chatsworth, CA, USA).
Cell culture and generation of stable transfectants
Chinese hamster ovary cells (CHO) were plated in 6-well tissue culture dishes (2610 5 cells/well) and grown to 30% con¯uence in Hams F-12 medium supplemented with 1 U/L penicillin, 1 mg/L streptomycin and 10% fetal bovine serum at 378C in a humidi®ed atmosphere of 5% CO 2 /95% air. DNA/lipid solution (1 ml) containing 1 mg p25B2-GFP, p25B3-GFP or pEGFP-C1 and 12 mg Lipofectamine reagent in supplemented medium was added to each coverslip of cells, and incubated as above. After 21 h, the DNA/lipid solution was replaced with supplemented medium. G418 (400 mg/ml) selection was initiated after an additional 24 h. Cells surviving after 19 days growth in G418-containing medium were analysed by¯uorescence microscopy using a conventional FITC ®lter set (Zeiss Axiovert 135; Carl Zeiss, Inc., Thornwood, NY, USA; Zeiss cube #10, BP 450-490). To enrich for the transfectants expressing the fusion proteins, we analysed cells by¯uorescence activated cell sorting (FACS; Becton Dickinson FACStar plus; Franklin Lakes, NJ, USA), collected the upper third of cells showing the highest uorescence and propagated them. This¯uorescence enrichment was repeated two times to obtain three stable populations of highly¯uorescent cells, corresponding to the above transfected DNA constructs. While some dimming of the¯uorescence intensity occurred over time (2 ± 3 months), FACS regenerated highly¯uorescent populations. All experiments reported here were performed on cells sorted three times. All cell culture reagents were purchased through Life Technologies.
Cell synchronization, drug treatments and¯uorescence analysis
Stable transfectants enriched for high¯uorescence were synchronized as previously described (Kruk et al., 1997) . Brie¯y, 10 5 exponentially growing cells were plated on 25 mm diameter circular coverslips. After 4 ± 8 h, the medium was replaced with starvation medium containing only 0.2% FBS for 48 h. Some coverslips (G1 cells) were used in experiments immediately following serum starvation, while the remainder were grown in medium containing 50 mM mimosine for 14 h, after which the medium was replaced with drug-free supplemented medium. At 4 h (S) and 8 h (G2/M) after mimosine removal, cells were used in experiments. Cell cycle phases were assigned to these times based on FACS analysis for DNA content of samples taken at 0, 4 and 8 h after mimosine removal. In this latter analysis, synchronized cells (3 ± 6610 6 ) were prepared by ®xing in 70% ethanol for 30 min at room temperature, digestion with 1 mg/ml RNase for 15 min at 378C, then staining with 10 mg/ml propidium iodide solution (Pastan, 1979) . G1, S, and G2/M synchronized cells were visualized by¯uorescence microscopy and distribution phenotypes were scored as cytoplasmic granules, diuse, nuclear or cytoplasmic. Ten ®elds of approximately 100 cells from duplicate coverslips were scored per experiment. The reported data were pooled from at least two independent experiments, and thus, represented a minimum of 4000 cells scored per cell line at each cell cycle phase. Where indicated, the synchronized cells were treated with 30 mM vanadate, 30 mM etoposide (Sigma, St Louis, MO, USA), or 100 nM okadaic acid (Alexis Biochemicals, San Diego, CA, USA) for 1 h prior to microscopic analysis. These concentrations were based on one third of the concentration required for 50% growth inhibition, as determined by cell viability assays.
Cell viability assay
GFP, Cdc25B 2 and Cdc25B 3 stable transfectants (enriched for uorescence) were exposed at 378C for 2 h to 30 nM ± 10 mM okadaic acid, 3 mM ± 1 mM sodium vanadate, or 10 mM ± 3 mM etoposide in supplemented Hams F-12 medium. Following incubation in drug-free medium for 72 h, viable cell number was determined by the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide as described previously (Woo and Lazo, 1997) .
Time lapse cinematography and quanti®cation of¯uorescent phenotypes
Time lapse shuttering of the Axiovert microscope was applied to the collection of¯uorescent images of live cell samples every 2.5 ± 10 min for 3 ± 10 h. These experiments were performed on a thermoplate set at 378C in a closed cell chamber to maintain appropriate temperature and pH conditions for the duration of the experiments.
